BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 2960768)

  • 1. Glycogen storage disease type II (Pompe's disease): the first biochemical evidence in Thailand.
    Rangdaeng S; Scollard DM; Srichairatanakol S; Sutthachit M; Phornphutkul C
    J Med Assoc Thai; 1987 Sep; 70(9):536-42. PubMed ID: 2960768
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biochemical diagnosis of glycogenosis type II (acid maltase deficiency) (author's transl)].
    Pilz H; Goebel HH; Stefan H; Seidel D; Kohlschütter A
    J Clin Chem Clin Biochem; 1977 Dec; 15(12):705-8. PubMed ID: 342670
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pompe's disease or glycogen storage disease].
    Vanto T; Salmi TT; Kalimo H; Lang H; Näntö V; Berlin M; Penttinen R
    Duodecim; 1982; 98(9):709-16. PubMed ID: 7049663
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acid alpha-glucosidase deficiency: Pompe's disease].
    Iwamasa T
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):686-92. PubMed ID: 3152090
    [No Abstract]   [Full Text] [Related]  

  • 5. Infantile-acute acid maltase deficiency (Pompe's disease): studies of muscle cultures.
    Meola G; Scarpini E; Manfredi L; Velicogna M; Pellegrini G; Redi CA; Scarlato G
    Basic Appl Histochem; 1984; 28(3):245-55. PubMed ID: 6440527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation for Pompé's disease.
    Hoogerbrugge PM; Wagemaker G; van Bekkum DW; Reuser AJ; vd Ploeg AT
    N Engl J Med; 1986 Jul; 315(1):65-6. PubMed ID: 3086726
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative investigation of alpha-glucosidase activity in leucocytes and skeletal muscle of patients with Morbus Pompe.
    Didt L; Winkler M; Bührdel P; Bormann M; Böhme HJ; Hofmann E
    Z Med Lab Diagn; 1988; 29(1):7-11. PubMed ID: 3129881
    [No Abstract]   [Full Text] [Related]  

  • 8. Receptor-mediated uptake of acid alpha-glucosidase corrects lysosomal glycogen storage in cultured skeletal muscle.
    Van der Ploeg AT; Loonen MC; Bolhuis PA; Busch HM; Reuser AJ; Galjaard H
    Pediatr Res; 1988 Jul; 24(1):90-4. PubMed ID: 2970619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of acid maltase protein in Pompe disease by use of immunohistochemical and enzyme immunoassay methods.
    Ninomiya N; Iwamasa T; Matsuda I; Nonaka I
    J Inherit Metab Dis; 1983; 6(3):131-2. PubMed ID: 6422147
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunochemical study of acid alpha-1,4-glucosidase in 7 patients with type II glycogenosis].
    Bienvenu J; Mathieu M; Collombel C; Baltassat P; Divry P; Dorche C; Cotte J
    Pediatrie; 1979 Sep; 34(6):659-76. PubMed ID: 388338
    [No Abstract]   [Full Text] [Related]  

  • 11. Tissue alpha-glucosidase activity and glycogen content in patients with generalized glycogenosis.
    Steinitz K; Rutenberg A
    Isr J Med Sci; 1967; 3(3):411-21. PubMed ID: 4951241
    [No Abstract]   [Full Text] [Related]  

  • 12. [Characterization of alpha-glucosidase in skin fibroblasts in the diagnosis of glycogenosis type 2 (Pompe disease)].
    Braulke T; Sandig KR
    Kinderarztl Prax; 1984 Aug; 52(8):377-82. PubMed ID: 6384623
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acid maltase deficiency in 2 adolescent siblings].
    Gracia P; Benlloch T; de la Fuente G; Durántez A; Espanña P; Cánovas A; Illera ER
    Med Clin (Barc); 1982 Sep; 79(5):227-31. PubMed ID: 6755088
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical diversity in glycogenosis type II. Biosynthesis and in situ localization of acid alpha-glucosidase in mutant fibroblasts.
    Reuser AJ; Kroos M; Willemsen R; Swallow D; Tager JM; Galjaard H
    J Clin Invest; 1987 Jun; 79(6):1689-99. PubMed ID: 3108320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vacuolar myopathy with type 2 A fiber atrophy and type 2 B fiber deficiency. A case of childhood form acid alpha-1,4-glucosidase deficiency.
    Matsuishi T; Terasawa K; Yoshida I; Yano E; Yamashita F; Hidaka T; Ishihara O; Yoshino M; Nonaka I; Kurokawa T; Nakamura Y
    Neuropediatrics; 1982 Nov; 13(4):173-6. PubMed ID: 6818487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of alpha-D-glucosidase activity in patients with Pompe's disease.
    Lin CY; Hwang B; Hsiao KJ; Jin YR
    Taiwan Yi Xue Hui Za Zhi; 1986 Aug; 85(8):766-70. PubMed ID: 3540186
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mitigated adult forms of acid maltase deficiency (Pompe's disease). Morphologic and pathobiochemical studies].
    Pongratz D; Hübner G; Deufel T; Wieland OH
    Klin Wochenschr; 1983 Aug; 61(15):743-50. PubMed ID: 6413751
    [No Abstract]   [Full Text] [Related]  

  • 18. [Late infantile form of Pompe's disease. Deficiency of alpha-1,4-glucosidase (acid maltase)].
    Colomer J; Roig M; Campistol J; Rullan G; Fernández-Alvarez E
    An Esp Pediatr; 1984 Sep; 21(3):250-9. PubMed ID: 6391315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ichthyosiform scaling in alpha-1,4-glucosidase deficiency].
    Gebhart W; Mainitz M; Jurecka W; Niebauer G; Paschke E; Stöckler S; Sluga E
    Hautarzt; 1988 Apr; 39(4):228-32. PubMed ID: 3290163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe course of glycogen storage disease type II (Pompe's disease) without development of cardiomegalia.
    Ullrich K; Gröbe H; Korinthenberg R; von Bassewitz DB
    Pathol Res Pract; 1986 Oct; 181(5):627-32. PubMed ID: 2947052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.